Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 5/20 | 0.67 |
| ▸ | HDAC4 | P56524 | 5/20 | 0.67 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.67 |
| ▸ | HDAC2 | Q92769 | 5/20 | 0.67 |
| ▸ | HDAC8 | Q9BY41 | 5/20 | 0.67 |
| ▸ | HDAC6 | Q9UBN7 | 5/20 | 0.67 |
| ▸ | HDAC7 | Q8WUI4 | 4/20 | 0.67 |
| ▸ | HDAC10 | Q969S8 | 4/20 | 0.67 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.67 |
| ▸ | HDAC9 | Q9UKV0 | 4/20 | 0.67 |
| ▸ | HDAC5 | Q9UQL6 | 4/20 | 0.67 |
| ▸ | MAOB | P27338 | 6/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| N-Isopropylcinnamamide SCHEMBL6751570 | 0.88 | TDP1 (0.73) | HDAC3HDAC4HDAC1HDAC2HDAC8 | |
| N-Isopropylcinnamamide SCHEMBL6751573 | 0.88 | TDP1 (0.73) | HDAC3HDAC4HDAC1HDAC2HDAC8 | |
| Juarezic Acid SCHEMBL28970789 | 0.85 | HDAC3 (0.53) | HDAC3HDAC4HDAC1HDAC2HDAC8 | |
| N-Isopropylcinnamamide SCHEMBL3963268 | 0.85 | TDP1 (0.69) | HDAC3HDAC4HDAC1HDAC2HDAC8 | |
| SCHEMBL402596 | 0.81 | HDAC3 (0.59) | HDAC3HDAC4HDAC1HDAC2HDAC8 | |
| SCHEMBL402595 | 0.81 | HDAC3 (0.59) | HDAC3HDAC4HDAC1HDAC2HDAC8 | |
| SCHEMBL23077927 | 0.79 | HDAC2 (0.96) | HDAC3HDAC4HDAC1HDAC2HDAC8 | |
| SCHEMBL10323570 | 0.79 | HDAC2 (0.96) | HDAC3HDAC4HDAC1HDAC2HDAC8 | |
| SCHEMBL13689262 | 0.77 | HDAC3 (0.58) | HDAC3HDAC4HDAC1HDAC2HDAC8 | |
| SCHEMBL14080852 | 0.77 | HDAC3 (0.67) | HDAC3HDAC4HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8163816-B2 | Production process of liquid composition, image forming process and image forming apparatus | CANON KABUSHIKI KAISHA (JP) | 2012-04-24 | — | — | US | disclosed |
| US-20110275774-A1 | ORGANOANTIMONY COMPOUND, PROCESS FOR PREPARING SAME, LIVING RADICAL POLYMERIZATION INITIATOR, PROCESS FOR PRODUCING POLYMER WITH USE OF SAME, AND THE POLYMER | YAMAGO SHIGERU | 2011-11-10 | — | — | US | disclosed |
| US-8008414-B2 | Organic antimony compound, process for producing the same, living radical polymerization initiator, process for producing polymer using the same, and polymer | OTSUKA CHEMICAL CO., LTD. (JP) | 2011-08-30 | — | — | US | disclosed |
| EP-1767539-B1 | ORGANIC ANTIMONY COMPOUND, PROCESS FOR PRODUCING THE SAME, LIVING RADICAL POLYMERIZATION INITIATOR, PROCESS FOR PRODUCING POLYMER USING THE SAME, AND POLYMER | OTSUKA CHEMICAL CO LTD (JP) | 2011-07-27 | — | — | EP | disclosed |
| US-20090299008-A1 | Organic antimony compound, process for producing the same, living radical polymerization initiator, process for producing polymer using the same, and polymer | OTSUKA CHEMICAL CO., LTD. (JP) | 2009-12-03 | — | — | US | disclosed |
| US-20070283847-A1 | PRODUCTION PROCESS OF LIQUID COMPOSITION, IMAGE FORMING PROCESS AND IMAGE FORMING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2007-12-13 | — | — | US | disclosed |
| EP-1767539-A1 | ORGANIC ANTIMONY COMPOUND, PROCESS FOR PRODUCING THE SAME, LIVING RADICAL POLYMERIZATION INITIATOR, PROCESS FOR PRODUCING POLYMER USING THE SAME, AND POLYMER | OTSUKA CHEMICAL COMPANY, LTD. (JP) | 2007-03-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090299008-A1 | Organic antimony compound, process for producing the same, living radical polymerization initiator, process for producing polymer using the same, and polymer | AOC2, ODC1, MCM7 | HDAC3 1896/4885HDAC4 2635/4885HDAC1 766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.